Teladoc Health (TDOC) Cash from Financing Activities (2014 - 2026)

Teladoc Health has disclosed Cash from Financing Activities across 13 years of filings, most recently posting $875000.0 for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 100.16% year-over-year to $875000.0; the TTM figure through Jun 2026 stood at -$4.1 million (up 99.26% YoY), while the FY2025 annual figure was -$551.7 million, down 6736.81% from the prior year.
• Cash from Financing Activities came in at $875000.0 for Q2 2026 at Teladoc Health, up from -$2.4 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.1 million in Q3 2023 to a low of -$549.9 million in Q2 2025.
• Average Cash from Financing Activities over 5 years is -$29.3 million, with a median of $989500.0 recorded in 2025.
• Year-over-year, Cash from Financing Activities soared 699.37% in 2023 and sank 14552.9% in 2025.
• Over 5 years, Cash from Financing Activities stood at $4.4 million in 2022, then slumped by 140.52% to -$1.8 million in 2023, then soared by 215.94% to $2.1 million in 2024, then plunged by 46.36% to $1.1 million in 2025, then dropped by 20.74% to $875000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $875000.0 in Q2 2026, -$2.4 million in Q1 2026, and $1.1 million in Q4 2025.